Elsamitrucin
Chemical compound
- none
- 10-[3-(3-Amino-5-hydroxy-4-methoxy-6-methyl-tetrahydro-pyran-2-yloxy)-4,5-dihydroxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy]-6-hydroxy-1-methyl-benzo[h]chromeno[5,4,3-cde]chromene-5,12-dione
- 97068-30-9 Y
- 5362259
- 4514988
- ZTV0FOB6NU
- DTXSID101028137
- Interactive image
- Cc1ccc2c3c1c(=O)oc4c3c(c(c5c4c(ccc5)O[C@H]6[C@@H]([C@@]([C@H]([C@H](O6)C)O)(C)O)O[C@@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)O)OC)N)O)c(=O)o2
InChI
- InChI=1S/C33H35NO13/c1-11-9-10-16-19-17(11)29(38)46-25-18-14(24(36)21(20(19)25)30(39)44-16)7-6-8-15(18)45-32-28(33(4,40)27(37)13(3)43-32)47-31-22(34)26(41-5)23(35)12(2)42-31/h6-10,12-13,22-23,26-28,31-32,35-37,40H,34H2,1-5H3/t12-,13-,22-,23+,26-,27+,28+,31-,32+,33+/m1/s1
- Key:MGQRRMONVLMKJL-KWJIQSIXSA-N
Elsamitrucin (elsamicin A) is a drug used in chemotherapy.[1] Elsamitrucin is chemically related to chartreusin.[citation needed]
References
- ^ Barceló F, Portugal J (October 2004). "Elsamicin A binding to DNA. A comparative thermodynamic characterization". FEBS Letters. 576 (1–2): 68–72. doi:10.1016/j.febslet.2004.08.063. PMID 15474012.
- v
- t
- e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
(M phase)
Block microtubule assembly | |
---|---|
Block microtubule disassembly |
inhibitor
DNA precursors/ antimetabolites (S phase) |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Topoisomerase inhibitors (S phase) |
| ||||||||
Crosslinking of DNA (CCNS) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e